The proviral DNA of chicken peripheral blood leukemic myeloblasts was analyzed by restriction endonuclease digestion and Southern blotting. Two restriction endonuclease-generated fragments, an EcoRI 2.2-megadalton (Md) and a HinduI 2.6-Md fragment, were present upon enzyme cleavage of all leukemic myeloblast DNA preparations in addition to endogenous or helper-specific fragments. Neither of these fragments was derived from viral DNA of the two known myeloblastosis-associated viruses (MAV-1 and MAV-2). In contrast, DNA similarly treated from the erythrocytes of leukemic chickens showed only small amounts of the two avian myeloblastosis virus-specific fragments, whereas the helper virus-specific fragments were present in the amount seen in MAV-producing chicken embryo fibroblasts. The appearance of the EcoRI 2.2-Md and HindIII 2.6-Md specific fragments in all leukemic myeloblast DNA preparations indicates they are presumably part of the leukemogenic genome that must be present to induce acute myeloblastic leukemia.
The proviral DNA of chicken peripheral blood leukemic myeloblasts was analyzed by restriction endonuclease digestion and Southern blotting. Two restriction endonuclease-generated fragments, an EcoRI 2.2-megadalton (Md) and a HinduI 2.6-Md fragment, were present upon enzyme cleavage of all leukemic myeloblast DNA preparations in addition to endogenous or helper-specific fragments. Neither of these fragments was derived from viral DNA of the two known myeloblastosis-associated viruses (MAV-1 and MAV-2). In contrast, DNA similarly treated from the erythrocytes of leukemic chickens showed only small amounts of the two avian myeloblastosis virus-specific fragments, whereas the helper virus-specific fragments were present in the amount seen in MAV-producing chicken embryo fibroblasts. The appearance of the EcoRI 2.2-Md and HindIII 2.6-Md specific fragments in all leukemic myeloblast DNA preparations indicates they are presumably part of the leukemogenic genome that must be present to induce acute myeloblastic leukemia.
Acute myeloblastic leukemia (AML) in chickens is induced by infection of hematopoietic target cells with the defective leukemogenic component of the avian myeloblastosis virus (AMV) complex that also includes two oncogenic helper viruses, myeloblastosis-associated virus types 1 and 2 (MAV-1 and MAV-2). AMV is thought to be defective because virus production is not detectable in some converted leukemic myeloblasts from which AMV can be rescued by superinfection with a suitable helper (11) .
Recently, we have identified a proviral genome associated with AMV-induced AML (17) which is different from either the MAV-1 or MAV-2 genome (4). This genome generates specific EcoRI and HindIll fragments and has a mass of approximately 4.9 megadaltons (Md) compared with 5.3 Md for MAV-1 or MAV-2. Also, preparations of unintegrated linear viral DNA from the AMV complex contain the same viral DNA genome in addition to the helper genomes (4) .
If the 4.9-Md viral genome is indeed the etiological agent of chicken AML, it should be present in all leukemic chicken myeloblasts regardless ofthe chicken strain infected, its endogenous proviral DNA background, or the AMV pseudotypes used in the infection. This presumptive AMV genome should also be present in myeloblasts conver in vitro by infection of yolk sac cell cultures $ In this study we have made a qualitative survey of proviral DNA in converted target cells (leukemic myeloblasts) and in infected but nonconverted cells (erythrocytes [RBC] ) from a variety of leukemic chickens. Our findings indicate that the presumptive AMV genome was present in the leukemic myeloblasts of every infected chicken, whereas MAV-1 or MAV-2 was not always present.
MATERIALS AND METHODS
Chicken strains and viruses. The strains and sources of our fertile chicken eggs were: C/E Spafas negative for group-specific antigen, chicken helper factor, and virus production (gs-chf V-) from Spafas, Inc., Roanoke, Ill.; C/O Spafas (gs-chf V-) from Life Sciences, Inc., St. Petersburg, Fla; and Hubbard cross rapid-growth broilers from Victor Ryckebosch, Inc., Lancaster, Calif. AMV-S. BAI strain A was kindly provided as frozen leukemic plasma by J. W. Beard (Life Sciences, Inc.). AMV-B (supernatant of cultured Spafas C/E leukemic myeloblasts producing AMV of subgroup B only) and AMV-C (AMV-C originated from a clone of nonproducer C/E Spafas leukemic myeloblasts superinfected with tdB77 subgroup C) were kindly provided by C. Moscosvici (Veterans Administration Hospital, Gainesville, Fla. 318 SOUZA AND BALUDA injection except for 22136, which developed AML 14 weeks after injection. Leukemic myeloblasts and RBC were isolated from chickens with AML as previously described (2) . Yolk sac cell cultures were prepared as described before (3) . EB32 leukemic myeloblasts were converted from AMV-B-infected C/E yolk sac cells (106 cells/60-mm dish). All leukemic myeloblasts were cultured as previously described (17) . CEF cultures were prepared from the thigh muscles of 11-day-old embryos. A C/O CEF culture at passage 6 was infected with AMV-S at a multiplicity of infection (MOI) of approximately 1 to 5. Chicken 21957 received 0.5 ml of supernatant (AMV-SC) intraperitoneally from the AMV-S-infected passage 6 CEF. C/E CEF were cloned at passage 1 in microtiter plates, and three clones of CEF that subsequently grew out were infected with AMV-S at an MOI of about 100. Spafas C/E chickens were injected intraperitoneally with 0.5 ml of supernatant from either AMV-S-infected clone 1, 2, or 4 (AMV-SC1, -2, or -4). In vitro assays for yolk sac cell conversion were carried out on 106 cells/60-mm dish infected with 2 ml of AMV-SC1, -2, or -4. Twenty-four hours after infection, the cultures were overlayed with 0.5% agar medium containing BM II (3), 5% calf serum, 5% heat-inactivated chick serum and 10% tryptose phosphate. Foci were counted in triplicate plates 15 days after infection.
Isolation and restriction endonuclease cleavage of cellular DNA. High-molecular-weight DNA from all infected tissues was isolated and treated with EcoRI or HindIII as previously described (17) . Highmolecular-weight DNA from uninfected embryos was isolated (6) and treated with EcoRI or HindIII as described before (15) . KpnI digests of 20 ,ig of cellular DNA were carried out in 6 mM Tris (pH 7.4), 6 mM NaCl, 6 mM MgCl2, 6 mM 2-mercaptoethanol, and 50 ,ug of gelatin per ml (Difco Laboratories, Detroit, Mich.). All restriction endonucleases were prepared in our laboratory. md Gels and transfer. Twenty micrograms of restriction endonuclease-digested DNA was loaded on 0.7% agarose (Sigma Chemical Co., St. Louis, Mo.; low electroendosmosis) gels run in 0.4 M Tris (pH 7.6), 50 mM sodium acetate, and 10 mM EDTA for approximately 20 h at 40 mA. The DNA in the gels was then transferred to nitrocellulose paper by the Southern technique.
Preparation of AMV-S "15I-70S RNA, hybridization, and autoradiography. 70S viral RNA isolated from AMV-S (14) was '25I labeled to a specific activity of 2.0 x 108 cpm/,ug and hybridized to Southern blots as previously described (15) . Autoradiography was carried out with Kodak X-Omat XR-5 film presensitized (9) and exposed at -70°C with a Dupont Hi-plus intensifying screen.
Interference assay. After six subculture passages, Spafas C/O CEF were infected at an MOI of 1 to 5 with AMV-S or AMV-B. After the infected cells were subcultured three more times, they were tested for their ability to interfere with either RSV (RAV-1) subgroup A or RSV (RAV-2) subgroup B. The interference assay was carried out by a modification of the Rubin procedure (12) . RESULTS
Endogenous proviral DNA. Since the endogenous proviral DNA complement varies from one strain of chickens to another and may even vary within a given strain (1, 7, 15) , the endogenous proviral DNA pattem of the various chicken strains used in this study was examined by restriction endonuclease digestion (Fig. 1) . Examination of six Spafas C/E chickens from Spafas, Inc., showed them to contain either of two endogenous proviral complements. These two patterns are shown in Fig. 1 (lanes g and h). The endogenous proviral complements for the Spafas C/O chickens we analyzed were identical to those of the Spafas C/E chickens. There was, however, a great degree of heterogeneity in the endogenous complement found in the commercially bred Hubbard chickens. To illustrate the pattern variations, EcoRI and HindIII digests of DNA from four Hubbard cross chicken embryos are shown in Fig. 1 , lanes c through f and i through 1. Hindm analysis of proviral DNA in leukemic myeloblasts. HindIII digestion of linear viral DNA from MAV-1, MAV-2 (4), or presumptive AMV (17) generates fragments of distinct size for each virus. HindIII digestion of MAV-1 proviral DNA yields internal viral DNA fragments of 2.3, 1.9, and 0.8 Md, and MAV-2 proviral DNA yields fragments of 3.1 and 1.9 Md (4). HindIl digestion of the presumptive AMV proviral genome obtained from peripheral blood leukemic myeloblasts and replicated as chimeric DNA in a X vector yields internal viral DNA fragments of 2.6 and 1.95 Md (17) . Also, HindIII cleaves these three viral genomes close to both the 3' and 5' termini (4, 17) . Thus, by analyzing the proviral fragments generated by HindIII digestion, we can determine which viral genomes are present in leukemic myeloblast DNA. This was done with DNA from peripheral blood leukemic myeloblasts converted by AMV-S, AMV-B, or AMV-C (Fig. 2) Fig. 3 . The digestion pattern for the leukemic DNA was identical to that for the uninfected DNA, indicating that there was no free tdB77 viral DNA. This leaves the possibility that a recombination event took place between AMV and tdB77 or an endogenous viral genome, creating a MAV-2-like genome.
Leukemic myeloblasts 21710 and EB32 were induced by AMV-B, but the exogenous band pattern indicated that the helper present in those cells resembled MAV-1 (subgroup A) and not MAV-2 (subgroup B). To ascertain that AMV-B was of subgroup B, we carried out an interference assay as described in Materials and Methods. We found, as previously reported (10) , that the AMV-B virus preparation contained only subgroup B virus, whereas AMV-S contained viruses of both A and B subgroups ( (Fig. 4d) . These two bands arose by cleavage of tdB77, which was the helper virus in AMV-C. EcoRI cleaves tdB77 internally and at both the 3' and 5' termini of the genome (5), generating three internal fragments of approximately 2.6, 1.7, and 0.9 Md. Thus, all the leukemic myeloblast DNAs examined did not contain detectable free linear viral DNA. Leukemic myeloblasts induced by AMV-S in Spafas chicken 21726 (Fig. 4c) were the only Spafas leukemic myeloblasts in which probable proviral juncture bands could be detected. It is not possible to ascertain whether any of the fragments generated by EcoRI digestion of DNA from Hubbard leukemic myeloblasts were juncture fragments because of the great complexity and diversity in the endogenous proviral com-IDENTIFICATION OF AMV GENOME. I. plement of these chickens. The two probable EcoRI juncture fragments in 21726 leukemic DNA have masses of 3.2 and 2.0 Md. The existence of two juncture bands in DNA from these leukemic myeloblasts was confirmed by analysis with KpnI, which cleaves only once the putative AMV or MAV-1-like genome (16) . Two bands of 15.0 and 10.0 Md in addition to the endogenous proviral pattern were generated by KpnI digestion of DNA from 21726 leukemic myeloblasts (Fig. 5b) . These two additional KpnI bands were not present in DNA from RBC of this leukemic chicken (Fig. 5a ). Also, AMV or MAV juncture bands were not detectable in DNA from RBC of this leukemic chicken (21726) by EcoRI analysis (Fig. 6e) .
Hindu and EcoRI analysis of proviral DNA in RBC from leukemic chickens. All the examined DNA preparations from leukemic myeloblasts contain a HindIII 2.6-Md fragment, signifying the presence of the putative AMV genome. Leukemic chickens have immature RBC and often acute anemia. Consequently, we investigated whether RBC from leukemic chickens infected with AMV-S or AMV-C also contain the putative AMV genome. After HindIII cleavage, DNA from the RBC of three chickens with AML induced by AMV-S showed two fragments of 1.95 and 0.8 Md in addition to their endogenous proviral pattern (Fig. 6a-c) . c) as well as from an AMV-C infected chicken (Fig. 6d) . The small amount of the HindIII 2.6-Md fragment in RBC could have resulted from contamination of the RBC preparation with some leukemic myeloblasts or from the presence of the putative AMV genome in only a fraction of the RBC. The RBC from leukemic chicken 22136 infected with AMV-C (tdB77) did not 6d) . Southern blots of EcoRI-digested RBC DNA from AMV-S-infected leukemic chickens showed a faint band at 2.2 Md in addition to the endogenous complement (Fig. 6e-h) . A faint band at 1.7 Md in the EcoRI-digested 22136 2 RBC DNA (Fig. 6h) indicated the presence of P tdB77 either in a small fraction of the RBC or in contaminating myeloblasts. The results confired those obtained with HindIII. Furthermore, the DNA preparations were free of linear C viral DNA, and specific juncture bands were not apparent in the RBC examined.
HindI and EcoRI analysis of proviral DNA in infected CEF. To further investigate the nature of the helper virus in AMV-B and the proviral content of nonconverted cells infected with AMV, we analyzed DNA from CEF cultures infected with AMV-S or AMV-B at an MOI of 1 to 5. HindIll analysis of the DNA from the infected CEF used in the interference assay (Table 1) is shown in Fig. 7a and b. The appearance of the MAV-1-specific 0.8-Md fragment indicates that both the AMV-S-and AMV-Binfected CEF cultures contained MAV-1-like proviral DNA. Again, as was seen in the AMV-B-induced leukemic myeloblasts, a MAV-1-like restriction pattern was apparent for the helper virus of AMV-B. The AMV-specific 2.6-Md and MAV-2-specific 3.1-Md fragments were not detectable. However, after injection of six Spafas C/E chickens with supernatant from these AMV-S-infected CEF cultures, two chickens died of AML ( Table 2 ). The AMV-specific HindIII 2.6-Md and EcoRI 2.2-Md fragments were present in leukemic myeloblast DNA from one of these chickens (21957) (Fig. 2e and 4e) . Supernatant from MAV-1-or MAV-2-infected CEF cultures did not induce AML in chickens nor did it convert yolk sac cultures (Table 2) . Chickens injected with MAV-2 developed osteogenic osteoblastomas and nephroblastomas, whereas MAV-1-injected chickens developed nephroblastomas.
To determine whether AMV in AMV-SC supernatant was produced by a few fibroblasts containing the AMV genome or by a few infected hematopoietic target cells contaminating the CEF culture, we infected CEF colonies derived from a single cell (clones). Three cloned CEF cultures were infected with AMV-S at an MOI of approximately 100. Two weeks after infection, the culture supernatant was used to infect yolk sac cultures and newly hatched chicks. Supernatant from all three AMV-S-infected cloned CEF caused acute myeloblastosis in chicks and converted yolk sac cells in vitro (Table 2) . HindIII digestion of DNA from AMV-S CEF clone 1 showed that these infected fibroblasts contained MAV-1, MAV-2, and the putative AMV genome (Fig. 7c) . However, not all cells necessarily contained all three genomes. HindIII analysis showed that DNA from leukemic myeloblasts of chicken 22141 infected with supernatant from AMV-S CEF clone 1 also contained all three genomes (Fig. 2b) . The other two infected CEF clones could not be analyzed in this manner because insufficient DNA was available. These data show that CEF can produce AMV and MAV-2 as well as integrate their DNA internediates. A linear DNA of 4.9 Md having the same mass as the putative AMV genome (17) could be synthesized in AMV-S-infected CEF (4).
EcoRI-cleaved DNA from AMV-S-or AMV-B-infected CEF did not appear to contain the AMV-specific 2.2-Md fragment if infection was carried out at low MOI (Fig. 7d, e) , but it did if infection was at high MOI (Fig. 7f) (17) . The mass of the putative AMV provirus corresponds to that found for a linear viral DNA in AMV-S linear viral DNA preparations (4).
We were surprised to find that the helper virus in AMV-B was not MAV-2, but a subgroup B virus which resembles MAV-1 in its HindIIl restriction pattern. By interference assay and restriction endonuclease analysis, the helper virus in both AMV-B-induced leukemic myeloblasts and AMV-B-infected CEF was identified as a subgroup B virus with a HindIII cleavage map identical to that of MAV-1. Also, despite the fact that the AMV-S-infected CEF used in the interference assay did not contain any detectable MAV-2 DNA, they too were resistant to superinfection by RSV (RAV-2), a subgroup B virus. In this connection, it should be pointed out that AMV-B was not isolated through the use of MAV-2 but was a chance isolate from a leukemic chicken (10) .
Leukemic myeloblasts would not exist nor would they be present and replicate in the peripheral blood of leukemic chickens if they did not contain the leukemogenic AMV genome, but they apparently do not need the helper provirus to express these malignant properties. There is no such selective pressure exerted on infected but not nonconverted celLs either in chickens (RBC) or in vitro (CEF), and their proviral DNA content reflects the higher concentration of helper viruses in the AMV inoculum. Even in RBC from leukemic chickens, the helper virus is usually readily detectable, whereas AMV is not. Similarly, most of the CEF infected in vitro with an AMV-S MOI of 1 (16) . Furthermore, the variation in the size of the juncture fragments from one cell clone to another indicates that there are multiple integration sites (16) . Therefore, the lack of detectable juncture fragments in peripheral blood leukemic myeloblasts may indicate that multiple target cells are converted in nearly all chickens infected with AMV.
